ANAB
Price
$24.69
Change
+$0.14 (+0.57%)
Updated
Aug 1 closing price
Capitalization
725.4M
9 days until earnings call
SPRY
Price
$17.18
Change
-$0.50 (-2.83%)
Updated
Aug 1 closing price
Capitalization
1.69B
4 days until earnings call
Interact to see
Advertisement

ANAB vs SPRY

Header iconANAB vs SPRY Comparison
Open Charts ANAB vs SPRYBanner chart's image
AnaptysBio
Price$24.69
Change+$0.14 (+0.57%)
Volume$326.87K
Capitalization725.4M
ARS Pharmaceuticals
Price$17.18
Change-$0.50 (-2.83%)
Volume$1.18M
Capitalization1.69B
ANAB vs SPRY Comparison Chart in %
Loading...
ANAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANAB vs. SPRY commentary
Aug 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANAB is a Hold and SPRY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 02, 2025
Stock price -- (ANAB: $24.69 vs. SPRY: $17.18)
Brand notoriety: ANAB and SPRY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANAB: 56% vs. SPRY: 87%
Market capitalization -- ANAB: $725.4M vs. SPRY: $1.69B
ANAB [@Biotechnology] is valued at $725.4M. SPRY’s [@Biotechnology] market capitalization is $1.69B. The market cap for tickers in the [@Biotechnology] industry ranges from $213.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANAB’s FA Score shows that 0 FA rating(s) are green whileSPRY’s FA Score has 0 green FA rating(s).

  • ANAB’s FA Score: 0 green, 5 red.
  • SPRY’s FA Score: 0 green, 5 red.
According to our system of comparison, both ANAB and SPRY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANAB’s TA Score shows that 5 TA indicator(s) are bullish while SPRY’s TA Score has 3 bullish TA indicator(s).

  • ANAB’s TA Score: 5 bullish, 4 bearish.
  • SPRY’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ANAB is a better buy in the short-term than SPRY.

Price Growth

ANAB (@Biotechnology) experienced а -8.35% price change this week, while SPRY (@Biotechnology) price change was -3.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.14%. For the same industry, the average monthly price growth was +15.55%, and the average quarterly price growth was +36.18%.

Reported Earning Dates

ANAB is expected to report earnings on Nov 11, 2025.

SPRY is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+0.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SPRY($1.69B) has a higher market cap than ANAB($725M). ANAB YTD gains are higher at: 86.480 vs. SPRY (62.844). SPRY has higher annual earnings (EBITDA): -27.07M vs. ANAB (-76.35M). ANAB has more cash in the bank: 340M vs. SPRY (276M). SPRY has less debt than ANAB: SPRY (73K) vs ANAB (15.6M). ANAB has higher revenues than SPRY: ANAB (112M) vs SPRY (97.1M).
ANABSPRYANAB / SPRY
Capitalization725M1.69B43%
EBITDA-76.35M-27.07M282%
Gain YTD86.48062.844138%
P/E RatioN/A151.25-
Revenue112M97.1M115%
Total Cash340M276M123%
Total Debt15.6M73K21,370%
FUNDAMENTALS RATINGS
ANAB: Fundamental Ratings
ANAB
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
PROFIT vs RISK RATING
1..100
91
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
74
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANABSPRY
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 3 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 3 days ago
77%
MACD
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 3 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 11 days ago
78%
Bullish Trend 17 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 12 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 3 days ago
84%
Aroon
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ANAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ULPSX109.80N/A
N/A
ProFunds UltraBull Svc
PRCEX27.47N/A
N/A
Principal Real Estate Securities C
RPPRX30.18N/A
N/A
Victory RS Partners R6
MUEVX39.33N/A
N/A
MFS Blended Research Core Equity R6
LSVFX11.07N/A
N/A
LSV Global Managed Volatility Instl

ANAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANAB has been loosely correlated with CLRB. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ANAB jumps, then CLRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANAB
1D Price
Change %
ANAB100%
+0.57%
CLRB - ANAB
40%
Loosely correlated
-1.26%
QTTB - ANAB
39%
Loosely correlated
-9.91%
ADCT - ANAB
39%
Loosely correlated
-2.89%
AMRN - ANAB
38%
Loosely correlated
+4.41%
IBRX - ANAB
36%
Loosely correlated
-3.66%
More

SPRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRY has been loosely correlated with LPCN. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRY jumps, then LPCN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRY
1D Price
Change %
SPRY100%
-2.83%
LPCN - SPRY
63%
Loosely correlated
-2.48%
XOMA - SPRY
37%
Loosely correlated
-0.44%
ANAB - SPRY
35%
Loosely correlated
+0.57%
RCUS - SPRY
35%
Loosely correlated
+0.33%
KROS - SPRY
34%
Loosely correlated
N/A
More